Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COMy Virtual 2020 | The Turkish COVID-19 clinical experience

Meral Beksac • 13 May 2020
COMy Virtual 2020

Meral Beksac, MD, Ankara University, Ankara, Turkey, provides us with an outline of the COVID-19 experience in Turkey. Specifically mentioned is the BCG vaccine and the low incidence and mortality rates in Turkey. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Meral Beksac

3:36
Ex vivo expanded NK cells for hematological cancer immunotherapy
Meral Beksac • 11 Dec 2023
3:52
EMN19: Dara-VCd in patients with multiple myeloma and extramedullary disease
Meral Beksac • 12 Dec 2023
2:16
The value of the early relapse EBMT score in multiple myeloma
Meral Beksac • 28 Sep 2023
1:30
Exploring the role of upfront autoSCT in multiple myeloma
Meral Beksac • 28 Sep 2023
The content of VJHemOnc is intended for healthcare professionals